Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01187771 · ClinicalTrials.gov registry record · Phase 2
Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial
A Phase 2 study of Obesity and Obstructive Sleep Apnea, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
- 2
- Study locations
NCT01187771 is a Phase 2 study of Obesity and Obstructive Sleep Apnea that has completed, run by University of Pittsburgh. The registered enrollment target is 53 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01187771, a Phase 2 study of Obesity and Obstructive Sleep Apnea, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the feasibility of conducting a comparative effectiveness study comparing a medical versus surgical approach to the initial management of obstructive sleep apnea (OSA) in the setting of obesity.
Conditions Studied
Interventions
- PROCEDURE Continuous Positive Airway Pressure
- PROCEDURE Laparoscopic Gastric Banding
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01187771
The ClinicalTrials.gov registry entry for NCT01187771 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Continuous Positive Airway Pressure is the first listed.
NCT01187771 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01187771 about?
NCT01187771 is a clinical study titled "Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial". The purpose of this study is to assess the feasibility of conducting a comparative effectiveness study comparing a medical versus surgical approach to the initial management of obstructive sleep apnea (OSA) in the setting of obesity.
What is the current status of trial NCT01187771?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2010-11. Estimated completion is 2014-12.
What conditions does trial NCT01187771 study?
This clinical trial studies the following conditions: Obesity, Obstructive Sleep Apnea.
What interventions are being tested in trial NCT01187771?
The interventions under investigation include: Continuous Positive Airway Pressure (PROCEDURE), Laparoscopic Gastric Banding (PROCEDURE).
Who is sponsoring clinical trial NCT01187771?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01187771 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.